EP. 1: Multiple Sclerosis and Risk of COVID-19
EP. 2: Disease-Modifying Therapies for MS During COVID-19
EP. 3: AAN 2020: Real-World Data on Cladribine Tablets for MS
EP. 4: Multiple Sclerosis: Takeaways From AAN 2020
EP. 5: MS Treatment Optimization During COVID-19
EP. 6: Treating Patients With MS During the COVID-19 Pandemic
EP. 7: AAN 2020 Data Release: Ofatumumab for Relapsing MS
EP. 8: Novel Oral Therapy for MS: AAN Data Updates
EP. 9: The Future of Multiple Sclerosis Management
